We are live on ! Find out more
ASTX

ASTEX PHARMACEUTICALS, INC COM
ASTX

Delisted

ASTX was delisted on the 10th of October, 2013.

Back to rankings

0 hedge funds and large institutions have $0 invested in ASTEX PHARMACEUTICALS, INC COM in 2013 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 123 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 123 → 0 (-123)

100% less capital invested

Capital invested by funds: $487M → $0 (-$487M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 123

Holders
–
Holders Change
-123
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
123
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
-$35.4M
2
BIT
BlackRock Institutional Trust
California
-$31.5M
3
TAL
TIG Advisors LLC
New York
-$30.8M
4
State Street
State Street
Massachusetts
-$30.1M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$27.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
CA
101
Cetera Advisors
Colorado
– -$114K -13,400 Closed
B
102
Barings
North Carolina
– -$106K -12,500 Closed
GMIM
103
General Motors Investment Management
New York
– -$102K -12,009 Closed
Los Angeles Capital Management
104
Los Angeles Capital Management
California
– -$90K -10,650 Closed
CAM
105
Capstone Asset Management
Texas
– -$89K -10,515 Closed
CPA
106
Cowen Prime Advisors
New York
– -$85K -10,000 Closed
STIA
107
Stone Toro Investment Advisers
New Jersey
– -$85K -10,000 Closed
Teacher Retirement System of Texas
108
Teacher Retirement System of Texas
Texas
– -$77K -9,050 Closed
TSW
109
Thompson Siegel & Walmsley
Virginia
– -$53K -6,200 Closed
Ameriprise
110
Ameriprise
Minnesota
– -$50K -5,927 Closed
Bank of America
111
Bank of America
North Carolina
– -$45K -5,301 Closed
PCM
112
Prelude Capital Management
New York
– -$44K -5,183 Closed
BlackRock
113
BlackRock
New York
– -$21K -2,487 Closed
PNC Financial Services Group
114
PNC Financial Services Group
Pennsylvania
– -$18K -2,109 Closed
Royal Bank of Canada
115
Royal Bank of Canada
Ontario, Canada
– -$16K -1,894 Closed
O
116
OppenheimerFunds
New York
– -$12K -1,400 Closed
BJ
117
BlackRock Japan
Japan
– -$10K -1,232 Closed
GT
118
Glenmede Trust
Pennsylvania
– -$8K -1,000 Closed
PMFA
119
Plante Moran Financial Advisors
Michigan
– -$7K -875 Closed
CFA
120
Carroll Financial Associates
North Carolina
– -$2K -300 Closed
LTFS
121
Ladenburg Thalmann Financial Services
Florida
– -$3K -300 Closed
MWP
122
MYCIO Wealth Partners
Pennsylvania
– -$1K -110 Closed
1 2 3 4
5

ASTX Hedge Fund Activity: Q4 2013 in Review

0 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in ASTEX PHARMACEUTICALS, INC COM (ASTX) for Q4 2013, worth a combined $0 — down 100% from $487M a quarter earlier.

Sellers outnumbered buyers: 123 funds closed out of ASTX and 0 opened new positions — a net loss of 123 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock Fund Advisors, exiting entirely with an estimated $35.4M sold.

  • 0 institutional investors held ASTEX PHARMACEUTICALS, INC COM (ASTX) as of Q4 2013, down from 123 in Q3 2013.
  • Funds reported $0 of ASTEX PHARMACEUTICALS, INC COM stock for Q4 2013, down 100% quarter-over-quarter.
  • 0 funds opened new ASTEX PHARMACEUTICALS, INC COM positions in Q4 2013 and 123 closed out, a net change of -123 holders.
  • The largest ASTEX PHARMACEUTICALS, INC COM seller in Q4 2013 was BlackRock Fund Advisors, an estimated $35.4M sold.

Based on aggregated 13F filings for Q4 2013.